Companion
Publication Biotechnology and Sustainable Development
Executive Summary
Back
to Table of Contents
The focus of the 2002 World
Summit on Sustainable Development is on improving the relationship between human
society and the natural environment. This document discusses the contributions
and consequences of current and future applications of gene technology in
agriculture, and the ways that these may affect human health and the
environment.
Present
contributions of gene technology to agriculture
The
contributions of gene technology to today’s agriculture are already
substantial. Discoveries in gene technology have led to:
·
Better understanding of
how plants function, and how they respond to the environment.
·
More targeted selection
objectives in breeding programs to improve the performance and productivity of
crops, trees, livestock and fish, and post harvest quality of food.
·
Use of molecular (DNA)
markers for smarter breeding, by enabling early generation selection for key
traits, thus reducing the need for extensive field selection.
·
Molecular tools for the
characterization, conservation and use of genetic resources
·
Powerful molecular
diagnostics, to assist in the improved diagnosis and management of parasites,
pests and pathogens.
·
Vaccines to protect
livestock and fish against lethal diseases.
It
seems likely that in most countries the applications of gene technology to
agriculture will be a two-stage process. Firstly, there are many applications of
gene technology that can be used to improve the management and efficiency of
present agricultural practices. Secondly, there are options for the targeted
introduction of transgenic strains, genetically modified for one or more
specific traits. Although transgenic strains of various species of crops, trees,
livestock and fish have been developed experimentally, only transgenic crop
varieties are in widespread commercial use in agriculture today.
Commercial
cultivation of transgenic crops
Broadly,
the first wave of genetically modified crops, which are in commercial use,
address production traits; the second wave, which are mainly under development,
address quality and nutritional traits; and the third wave address complex
stress response traits and novel products able to be produced in plants. The
scientific basis of dealing with each of these groups of traits is increasingly
complex.
The production traits targeted in the
first wave of transgenic crop varieties specifically addressed the economic and
environmental costs of agronomic practices and chemical management in
large-scale agriculture. An important factor in the initial choice of production
traits was the fact that the major early private investors in plant
biotechnology were several multinational chemical companies. The long-term
viability of chemically based agriculture was being questioned. A combination of
new scientific possibilities, business opportunities, and decreasing viability
of chemically-based agriculture led to the targeting of particular production
traits (particularly insect resistance and herbicide tolerance) and their
subsequent commercial development into new transgenic crop varieties.
The
first transgenic plant was produced experimentally in 1983. The first commercial
cultivation was in 1995. By 2001, there were almost 53 million hectares of
genetically modified crops growing in thirteen countries. These crops are mainly
soybean, corn, cotton and oil seed rape, with resistance to certain insects
and/or herbicide tolerance. Many other crops and traits are under investigation
but most have yet to be taken through to practical use.
Trait selection
The
developers of the first generation of genetically modified organisms faced a
number of technical limitations that influenced the choice of species and traits
that have been taken through to full product development. The constraints
include:
(1) The availability of genes
controlling traits that could be manipulated. Initially only traits controlled
by single genes could be manipulated. Most characteristics of food, yield, and
responses to stress are complex traits, controlled by several genes.
(2) The efficiency of the methods
to produce genetically modified organisms that express the desired trait
consistently under field conditions;
(3) The need to meet evolving
regulatory requirements for new crop varieties and other living modified
organisms (LMOs) containing genes from outside their normal range of
hybridization.
Management of single gene production
traits: The careful
targeting and correct management of single gene traits is critical for their
successful use in agriculture, so as to avoid the boom/bust cycles typical of
single gene resistance. In the deployment of new transgenic varieties of Bt-crops,
such as cotton and corn, in broad scale agriculture, much effort has gone into
devising and implementing specific crop management arrangements that lessen the
pressure for the evolution of resistance in the target pest. These crop
cultivation regimes include leaving some of the field as non-transgenic,
susceptible crops (providing refugia for the insects) or to include in the plant
two or more different genes for pest resistance (gene stacking).
Back to top
Dealing with complex traits
Emerging
scientific developments are enabling complex traits to be addressed, with the
intention of developing new products of potential value for agriculture, human
health and the environment. The attractiveness of the new targets is tempered by
the fact that they are technically difficult, requiring the expression and
control of multiple genes, often involved in different biochemical pathways. The
new targets include traits for:
Increasing sustainable agricultural
production, by the
cultivation of crops that are better able to tolerate biotic stresses (pests,
diseases and weeds) and abiotic stresses (drought, salinity, and temperature
stress).
Delivering health benefits through
more nutritionally beneficial foods, with higher content of essential vitamins
and minerals, especially in staple crops; and reducing allergenic, carcinogenic
and/or toxic compounds in certain plants.
Using plants for pharmaceutical production: More
economical and efficient production of vaccines against human diseases, and
other pharmaceuticals in plants.
Using plants for production of products for
industrial purposes: including novel compounds
such as biodegradable plastics and industrial strength fibers.
Environmental benefits:
Using plants (and microbes) to mitigate the effects of industrial pollution (bioremediation),
by increasing their ability to remove and/or break down toxic compounds in the
soil.
Back to top
Emerging scientific discoveries
Recent
scientific developments confer the ability to study the structure and function
of all the genes within an organism simultaneously (through genomics),
as well as the protein products they code for (through proteomics).
It is also possible to study the role of all the chemical compounds in the
metabolism of the cell (through metabolomics).
These emerging scientific developments are being greatly assisted by powerful
computing and statistical techniques that enable the assembly, interrogation and
interpretation of large databases (through bioinformatics). New terms are being coined to describe these
rapidly evolving branches of science and the techniques on which they are based.
The
emerging scientific possibilities also pose new challenges in the assessments of
the risks and benefits of potential new products to human health and the
environment. Some of the potential products are meant for food or feed use,
while others are intended for use as pharmaceuticals, and others as compounds
for industrial uses. Some will require inter-specific transfer and control of
multiple genes. Others will rely on switching on (or off) and better regulating
genes that are already present in the organism but not usually expressed.
The
new scientific developments also offer potential means to overcome some of the
perceived risks
in the cultivation of genetically modified crops. These include limiting
the unintentional movement of genes out of the target crop (through gene
containment); better food safety
assessments of unintended changes in the composition of foods by assessments of
the content of whole foods (through metabolomics);
and the removal of antibiotic resistant, selectable markers from GM foods.
The
challenge is how emerging scientific discoveries, such as those in the rapidly
evolving fields of genomics, proteomics
and metabolomics, amongst others,
can be translated into safe applications of biotechnology that will lead to new
varieties of crops, novel foods and new products that deliver benefits for
society. These new applications and their risks and benefits will differ in
different parts of the world.
Careful thought needs to be given to
identifying the most suitable targets and desirable traits for future research
and development efforts, in different countries and environments.
Back to top
New understanding of plant and animal
genes through genomics: Genomics
refers to the processes used in identifying the location and function of all the
genes contained in an organism. This new knowledge will change the future of
breeding for improved strains of all domesticated species of crops, livestock,
fish, and tree species.
Twelve
crops, five livestock and two fish species provide over 90% of the world’s
food.
For these staple species, national and international public sector research has
made a large investment in genetic resources and breeding materials, and has an
understanding of their behavior in different environments. These scientific and
biological resources will become increasingly important in gaining knowledge
about the function of genes, in developing molecular markers and other means to
assist in the breeding of improved strains.
The first plant genome that has been
completely sequenced is a small, model species, Arabidopsis
thaliana. The genomic sequencing of
economically important crops is also being undertaken. The most advanced are the
several public and private gene sequencing projects on rice, all of which are
now in the public domain. A maize genome-sequencing project is also in progress.
Rice, maize and other cereals share a large number of common genes. Several
other genome sequencing projects of at least 120 different plant species are in
progress.
Understanding the role of proteins
through proteomics: Most
cellular functions are carried out by multi-protein complexes. New techniques
are enabling these complexes to be unravelled, and the functions of individual
proteins understood. These techniques
allow the identification and quantification of proteins expressed in a
particular tissue or in a specific developmental or environmental condition,
such as in response to stress.
Understanding
what happens in the cell through metabolomics:
Information on
metabolite levels in the cell is critical to obtaining an overview of a
biological process. Examining changes in metabolic profiles is an important part
of assessing gene function and relationships of phenotypes. Modern high-resolution
techniques allow the establishment of a profile of all metabolites present in a
specific plant tissue. A variety of previously unidentified biochemical pathways
can now be understood. Metabolomics can also provide information on
metabolic network regulation in response to genetic and environmental
perturbations, leading to a better understanding of plant responses to stress. Extensive
databases of quantitative information are being developed about the degree to
which each gene responds to environmental stimuli, such as biotic and abiotic
stresses. These databases will provide insights into the set of genes that
control complex responses and will create powerful opportunities to assign
functional information to genes of otherwise unknown function
Metabolic engineering: Metabolic
engineering is the in vivo manipulation of biochemistry to enable plants to
produce non-protein products or to alter cellular properties. The products may
be native to the plant or novel (expressed after the introduction of genes from
another source). Recent research shows that it is technically possible to
produce the following products in plants at the experimental level: Vitamin A
precursors; essential oils; medicinally important alkaloids; biodegradable
plastics; vaccines. Several of these products are now in development phase and
are coming forward for regulatory approval.
Back to top
Understanding
risks and benefits of gene technology
The
rapid increase in the use of new techniques for understanding and modifying the
genetics of living organisms has led to greatly increased interest and
investments in biotechnology. These developments have been accompanied by public
concerns as to the power of the new technologies and the safety and ethics of
their use for improving human health, agriculture and the environment.
Public concerns about
the applications of biotechnology lie in four major areas: (1) Ethical issues; (2) Socio-economic effects; (3)Food safety and
human health; and (4) Impact on biodiversity and the environment. In
agriculture, these concerns relate particularly to the release of living
modified organisms (LMOs) for agricultural purposes. These organisms may be
plants, trees, livestock, fish and/or microorganisms.
The ethical
issues relate to moral and social concerns about the nature of gene
technology itself and the consequences of its use in specific situations. There
are concerns about the appropriateness of the use of intellectual property
rights in relation to living organisms, and means to ensure the equitable
sharing of benefits by holders of genetic resources, owners of indigenous
knowledge and inventors.
Socio-economic
effects are concerned with
the economic risks and benefits in the use of new biotechnology applications,
the implications of intellectual property management on agriculture in different
countries and in identifying who gains and who loses from the use of new
technologies in various circumstances.
In relation to food safety and human health, there are concerns as to assessing the
risks of genetically modified foods to human health, in the short and long term;
identifying specific nutritional benefits of genetically modified foods
developed for this purpose; and searching for any unintended effects of genetic
modifications on food.
In relation to impact on biodiversity and other possible environmental effects, the concerns relate to assessing the risks
and benefits of releasing living modified organisms into the environment, and
the effects such releases may have on the environment. These effects may be
through direct effects on the environment, including potential impact on
biodiversity, and/ or indirect effects
through changing agricultural practices that affect the environment.
Consideration
of all these issues, on a case by case basis, provides a basis for choices on
the merits and safety of the applications of new biotechnologies to address
particular problems, relative to existing agricultural technologies and other
technology options. All these issues are important in making choices on the use
of gene technology to address particular aspects of sustainable development.
This document addresses specifically the emerging scientific trends; the
scientific basis of assessing the effects of gene technology on food safety and
human health; and the impact of gene technology on biodiversity and the
environment.
Back to top
Conclusion
Achieving
the potential applications of modern molecular science will require substantial
private and public investments, and a wide range of scientific skills. These
required skills lie not only in gene technology, but also in the related fields
of plant breeding, agronomy and physiology, food and nutrition and in natural
resources management. There also needs to be greatly improved linkages amongst
the social, scientific, industrial and environmental communities, so as to
better define the ways in which science can benefit society and to design new
technologies in ways that are socially and environmentally acceptable and
beneficial in different countries and communities.
New
developments in science and technology, including the continuing discoveries in
gene technology, can contribute to achieving strategies for sustainable
development, if they are:
·
Directed
at clearly defined targets that affect poverty reduction, food security,
environmental conservation and/or trade competitiveness;
·
Accompanied
by political will, supportive public policies, and public and private
investments in both science and technology and product development and delivery;
·
Implemented
under the auspices of transparent regulatory frameworks that generate public
trust and confidence in the safety and ethical use of new biological products
and processes for human health, agriculture and the environment.
This
overview document will be complemented by a meta-review commissioned by ICSU
that is analysing the key findings of reviews on GM foods and crops
that have been conducted by various national, international and private agencies
within the past three years. Particular attention is being given to identifying
the areas of commonality amongst the reviews, identifying any areas of differing
perspective, and highlighting those areas where there are gaps in knowledge that
may be able to be addressed through additional well targeted research.
Back to top
Go to Chapter 1 - Overview